New overview of medicines for type 2 diabetes
Medicinrådet publishes treatment algorithm and overview of recommended medicines for type 2 diabetes based on efficacy, adverse effects and price.
Medicinrådet (Danish Medicines Council) · Denmark
Jurisdiction
Denmark
Regulation
Category
Type · Breadth
Date
New treatment guidance for type 2 diabetes
29. maj 2026
Medicinrådet (Danish Medicines Council) · DenmarkNew national basic medicines list for general practitioners from Medicinrådet
Medicinrådet publishes a new national basic medicines list replacing regional lists, covering 15 common disease areas with drug-choice recommendations for primary care.
Medicinrådet (Danish Medicines Council) · DenmarkNew short guidance for psychiatrists and general practitioners on ADHD medication
Danish Medicines Council publishes new brief guidance for psychiatrists and GPs on ADHD medication prescribing.
Medicinrådet (Danish Medicines Council) · DenmarkNew portal makes it easier for companies to apply to the Danish Medicines Council
Medicinrådet launches a digital applicant portal on 5 October 2026 for companies to submit requests for assessment of new medicines for standard treatment in the Danish health system.
Medicinrådet (Danish Medicines Council) · DenmarkNew process for immunotherapies shows results
Danish Medicines Council introduced a streamlined fast-track assessment process for PD-(L)1 inhibitors in metastatic cancer, enabling evaluation in weeks; 22 medicines approved under the new model since June 2026.
Medicinrådet (Danish Medicines Council) · DenmarkMedicinrådet assessment of new W.A.I.T figures
20. maj 2026
Medicinrådet (Danish Medicines Council) · DenmarkOverview: Medicinrådet decisions in May 2026
29. maj 2026
Medicinrådet (Danish Medicines Council) · DenmarkMedicinrådet collaborates with DARE on real-world data
Danish Medicines Council launches two pilot projects with Danish Alliance for Real-World Evidence to analyse real-world effectiveness of recommended cancer medicines in Danish clinical practice.
Medicinrådet (Danish Medicines Council) · DenmarkMedicinrådet and Amgros extend deadline for pharmaceutical companies to propose alternative pricing agreements
The Danish Medicines Council and Amgros have extended the deadline for pharmaceutical companies to propose alternative pricing agreements.
Medicinrådet (Danish Medicines Council) · DenmarkMedicinrådet appoints new center director for chronic diseases
Lisbeth Bonefeld er uddannet farmaceut og har mere end 25 års erfaring fra forskellige stillinger i Novo Nordisk. Lisbeth har blandt andet stået i spidsen for internationale fase III-studier, arbejdet med udvikling af...
Medicinrådet (Danish Medicines Council) · DenmarkNew organisation of the Danish Medicines Council secretariat from 1 June 2026
01. juni 2026
Medicinrådet (Danish Medicines Council) · DenmarkMedicinrådet appoints new centre director and strengthens cancer area
06. maj 2026
Medicinrådet (Danish Medicines Council) · DenmarkMedicinrådet decisions overview: June 2026
Danish Medicines Council recommends durvalumab in combination with FLOT for resectable gastric cancer patients receiving perioperative treatment.
Medicinrådet (Danish Medicines Council) · DenmarkMedicinrådet does not recommend givinostat due to uncertainty about effect size and duration in Duchenne muscular dystrophy patients
Danish Medicines Council recommends against reimbursement of givinostat for Duchenne muscular dystrophy due to uncertain efficacy evidence and high price.
Medicinrådet (Danish Medicines Council) · Denmark
Showing 15 of 15 tracked updates
Health-tech only
See all in the feed →